These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
515 related articles for article (PubMed ID: 25619725)
1. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa. Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725 [TBL] [Abstract][Full Text] [Related]
2. Cellular expression and siRNA-mediated interference of rhodopsin cis-acting splicing mutants associated with autosomal dominant retinitis pigmentosa. Hernan I; Gamundi MJ; Planas E; Borràs E; Maseras M; Carballo M Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3723-9. PubMed ID: 21357407 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional expression of cis-acting and trans-acting splicing mutations cause autosomal dominant retinitis pigmentosa. Gamundi MJ; Hernan I; Muntanyola M; Maseras M; López-Romero P; Alvarez R; Dopazo A; Borrego S; Carballo M Hum Mutat; 2008 Jun; 29(6):869-78. PubMed ID: 18412284 [TBL] [Abstract][Full Text] [Related]
4. Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa. Orlans HO; McClements ME; Barnard AR; Martinez-Fernandez de la Camara C; MacLaren RE Nat Commun; 2021 Aug; 12(1):4934. PubMed ID: 34400638 [TBL] [Abstract][Full Text] [Related]
5. The nature of dominant mutations of rhodopsin and implications for gene therapy. Wilson JH; Wensel TG Mol Neurobiol; 2003 Oct; 28(2):149-58. PubMed ID: 14576453 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy in animal models of autosomal dominant retinitis pigmentosa. Rossmiller B; Mao H; Lewin AS Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406 [TBL] [Abstract][Full Text] [Related]
7. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa. Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223 [TBL] [Abstract][Full Text] [Related]
8. New mutation in the 3'-acceptor splice site of intron 4 in the rhodopsin gene associated with autosomal dominant retinitis pigmentosa in a Basque family. Reig C; Alvarez AI; Tejada I; Molina M; Aróstegui E; Martín R; Antich J; Carballo M Hum Mutat; 1996; 8(1):93-4. PubMed ID: 8807346 [No Abstract] [Full Text] [Related]
9. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa. O'Reilly M; Millington-Ward S; Palfi A; Chadderton N; Cronin T; McNally N; Humphries MM; Humphries P; Kenna PF; Farrar GJ Vision Res; 2008 Feb; 48(3):386-91. PubMed ID: 17920651 [TBL] [Abstract][Full Text] [Related]
10. Course of Ocular Function in PRPF31 Retinitis Pigmentosa. Hafler BP; Comander J; Weigel DiFranco C; Place EM; Pierce EA Semin Ophthalmol; 2016; 31(1-2):49-52. PubMed ID: 26959129 [TBL] [Abstract][Full Text] [Related]
11. Knockdown of wild-type mouse rhodopsin using an AAV vectored ribozyme as part of an RNA replacement approach. Gorbatyuk MS; Pang JJ; Thomas J; Hauswirth WW; Lewin AS Mol Vis; 2005 Aug; 11():648-56. PubMed ID: 16145542 [TBL] [Abstract][Full Text] [Related]
12. Identification of photoreceptor genes affected by PRPF31 mutations associated with autosomal dominant retinitis pigmentosa. Mordes D; Yuan L; Xu L; Kawada M; Molday RS; Wu JY Neurobiol Dis; 2007 May; 26(2):291-300. PubMed ID: 17350276 [TBL] [Abstract][Full Text] [Related]
13. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Lewin AS; Drenser KA; Hauswirth WW; Nishikawa S; Yasumura D; Flannery JG; LaVail MM Nat Med; 1998 Aug; 4(8):967-71. PubMed ID: 9701253 [TBL] [Abstract][Full Text] [Related]
14. The severe autosomal dominant retinitis pigmentosa rhodopsin mutant Ter349Glu mislocalizes and induces rapid rod cell death. Hollingsworth TJ; Gross AK J Biol Chem; 2013 Oct; 288(40):29047-55. PubMed ID: 23940033 [TBL] [Abstract][Full Text] [Related]
15. Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model. Patrizi C; Llado M; Benati D; Iodice C; Marrocco E; Guarascio R; Surace EM; Cheetham ME; Auricchio A; Recchia A Am J Hum Genet; 2021 Feb; 108(2):295-308. PubMed ID: 33508235 [TBL] [Abstract][Full Text] [Related]
16. Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa. Mussolino C; Sanges D; Marrocco E; Bonetti C; Di Vicino U; Marigo V; Auricchio A; Meroni G; Surace EM EMBO Mol Med; 2011 Mar; 3(3):118-28. PubMed ID: 21268285 [TBL] [Abstract][Full Text] [Related]
17. Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa. Sun X; Liang C; Chen Y; Cui T; Han J; Dai M; Zhang Y; Zhou Q; Li W Hum Gene Ther; 2024 Mar; 35(5-6):151-162. PubMed ID: 38368562 [TBL] [Abstract][Full Text] [Related]
18. Mice with a D190N mutation in the gene encoding rhodopsin: a model for human autosomal-dominant retinitis pigmentosa. Sancho-Pelluz J; Tosi J; Hsu CW; Lee F; Wolpert K; Tabacaru MR; Greenberg JP; Tsang SH; Lin CS Mol Med; 2012 May; 18(1):549-55. PubMed ID: 22252712 [TBL] [Abstract][Full Text] [Related]